Indiva ceases production of THC lozenges over misclassification

Health Canada said products should be classified as edibles, not extracts.

Indiva Limited has suspended production of its THC lozenges after Heath Canada determined the company misclassified the products.

Indiva said the Canadian agency ruled that the company’s Wild Cherry THC Lozenges and Life Lemon THC Lozenges - available in 100 mg, 250 mg and 500 mg package formats - should be classified as “edibles,” rather than “extracts,” under applicable cannabis regulations.

Indiva noted that before it introduced the lozenges, the company “closely considered the regulatory requirements of the legislation, including with respect to product classification, and conducted substantial research” before classifying the lozenges as cannabis extracts.

While Health Canada has requested that Indiva cease production of the lozenges, the company said it may choose to continue manufacturing the products in alternative packaging formats.

Alyse Thompson-Richards has held many positions with BNP Media, first serving as an intern at Candy Industry Magazine in summer 2012. She joined Candy Industry's staff full time as associate editor in August 2016 after a few years at newspapers in West-Central Illinois, becoming managing editor in March 2019. Alyse has also served on Cannabis Products Insider since March 2019. She has bachelor’s degrees in journalism and Spanish from Western Illinois University.